Simian virus 40, poliovaccines and human tumors: A review of recent developments

Oncogene

Volumn 15, Issue 16, 1997, Pages 1877-1888

  Carbone, Michele ^a   Rizzo, Paola ^a   Pass, Harvey I ^b  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Human tumors; Poliovaccines; SV40

Indexed keywords

ASBESTOS; CARCINOGEN; POLIOMYELITIS VACCINE;

CHOROID PLEXUS TUMOR; DNA SEQUENCE; DRUG CONTAMINATION; EPENDYMOMA; FOOD AND DRUG ADMINISTRATION; HAMSTER; HEALTH CARE ORGANIZATION; HUMAN; MESOTHELIOMA; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; REVIEW; SARCOMA; SIMIAN VIRUS 40; VIRUS CARCINOGENESIS;

CRICETINAE; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; TUMOR VIRUS;

EID: 0030671131     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201375     Document Type: Review

References (83)

1. Appel JD, Fasy TM, Kohtz DS, and Johnson EM. (1988). Proc. Natl. Acad. Sci. USA, 85, 7670-7674.
2. Avantaggiati ML, Carbone M, Graessman A, Nakatani Y, Howard B, and Levine AS. (1996). EMBO J., 15, 2236-2248.
3. Banga SS, Kim S, Hubbard K, Dasgupta T, Jha KK, Patsalis P, Hauptschein R, Gamberi B, Dalla-Favera R, Kraemer P, and Ozer HL. (1997). Oncogene, 14, 313-321.
4. Bell DW, Jhanwar SC, & Testa JR. (1997). Proceedings of the IV International Mesothelioma Conference. University of Pennsylvania, Philadelphia PA, May 13-15. G4, pp. 27.
5. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, and Garcea R. (1992). N. Engl. J. Med., 36, 988-993.
6. Bikel I, Montano X, Agha ME, Brown M, McCormack M, Boltax J, and Livingston DM. (1987). Cell, 48, 321-330.
7. Bright RK, Shearer MH, and Kennedy RC. (1994). Clin. Exp. Immunol., 96, 491-499.
8. Carbone M, Lewis AM Jr, Matthews BJ, Levine AS, and Dixon K. (1989). Cancer Res., 49, 1565-1571.
9. Carbone M, Pompetti F, Cicala C, Nguyen F, Dixon K, and Levine AS. (1991). In: Molecular basis of human cancer, Nicolini C (ed.), Plenum Publishing Co New York, pp. 191-206.
10. Carbone M, Pass HI, Rizzo P, Marinetti MR, Di Muzio M, Mew DJY, Levine AS, and Procopio A. (1994). Oncogene, 9, 1781-1790.
11. Carbone M, Rizzo P, Procopio A, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD, and Garcea RL. (1996). Oncogene, 13, 527-535.
12. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJY, de Bartolomeis A, Esposito V, Shridar V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, and Pass HI. Nature Med., In press.
13. Cicala C, Pompeti F, Nguyen P, Dixon K, Levine AS, and Carbone M. (1992). Virology, 190, 475-479.
14. Cicala C, Pompetti F, & Carbone M. (1993). Am. J. Pathol., 142, 1524-1533.
15. Cicala C, Avantaggiati ML, Graessmann A, Rundell K, Levine AS, and Carbone M. (1994). J. Virol., 68, 3138-3144.
16. Cole NC. (1996). In: Virology. Fields BN, Knipe DM, Howley PM (eds), Lippincott-Raven Publishers: Philadelphia, New York, vol. 2, pp. 1997-2025.
17. Communicable Disease Center, Report NO. 248 (1961).
18. Cristaudo A, Vivaldi A, Sensales G, Guglielmi G, Ciancia E, Elisei R and Ottenga F. (1995). J Env. Pathol. Toxicol. Oncol., 14, 29-34.
19. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M amd Giordano A. Nature Med. In press.
20. De Villers E. (1997). SV40: A possible human polyomavirus workshop. National Institutes of Health, Bethesda, MD. 27-28 Jan. 1997. Transcripts. SAG, Corp. Washington DC 20008. (vol. 1) pp. 176-180.
21. Diamandopoulous GT. (1972). Science, 176, 73-75.
22. Dixon K, Ryder BJ, and Burche-Jaffe E. (1982). Nature, 296, 672-675.
23. Dubes GR. (1993). Proc. Am. Assoc. Cancer Res., 34, 185 (abs.)
24. Eddy BE, Borman GS, Berkeley WH, and Young RD. (1961). Proc. Soc. Exptl. Biol. Med., 107, 191-197.
25. Eddy BE, Borman GS, Grubbs GE and Young RD. (1962). Virology, 17, 65-75.
26. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, and Hennighausen L. (1996). Science, 273, 1384-1387.
27. Fanning E and Knippers R. (1992). Annu. Rev. Biochem., 61, 55-85.
28. Fraumeni J, Ederer F and Miller RW. (1963). JAMA., 185, 713-718.
29. Frost JA, Alberts AS, Sontag E, Guan K, Mumby MC, and Feramisco JR. (1994).Mol. Cell. Biol., 14, 6244-6252.
30. Galateau-Sallè F. (1997). SV40: A possible human polyomavirus workshop. National Institutes of Health, Bethesda, MD. 27-28 Jan. 1997. Transcripts. SAG, Corp. Washington DC 20008. (vol. 1) pp. 186-188.
31. Geissler E. (1990). Prog. Med. Virol., 37, 211-222.
32. Griffiths D, and Weiss R. (1997). SV40: A possible human poliomavirus workshop. National Institutes of Health, Bethesda, MD. 27-28 Jan. 1997. Transcripts. SAG, Corp. Washington DC 20008. (vol. 1) pp. 171-176.
33. Ilyinskii PO, Daniel MD, Horvath CJ, and Desrosiers RC. (1992). J. Virol., 66, 6353-6360.
34. Jensen F, Koprowski H, Pagano JS, Ponten J, and Ravdin RG. (1964). J. Natl. Cancer Inst., 32, 917-932.
35. Kirschstein RL, and Gerber P. (1962). Nature, 195, 299-300.
36. Krieg P, Amtmann E, Jonas D, Fisher H, Zang K, and Sauer G. (1981). Proc. Natl. Acad. Sci. USA, 78, 6446-6450.
37. La Bella F and Ozer HI. (1985). Virus Res., 2, 329-343.
38. Lednicky JA, Garcea RL, Bergsagel DJ and Butel JS. (1995a). Virology, 212, 710-717.
39. Lednicky JA, Wong C and Butel JS. (1995b). Virus Res., 35, 143-153.
40. Lednicky JA, Stewart AR, Jenkins JJ, Finegold MJ and Butel JS. Int. J. Cancer, In press.
41. Lewis, AM Jr. (1973). In: Biohazards in Biological Research. Hellman A, Oxman M, and Pollack R (eds.), Cold Spring Harbor Lab Press, New York, NY, pp.96-113.
42. Lewis AM Jr and Martin RG. (1979). Proc. Natl. Acad. Sci. USA, 76, 4299-4302.
43. Lill NL, Tevethia MJ, Eckner R, Livingston DM, and Modjtahedi N. (1997). J. Virol., 71, 129-137.
44. Linnainmaa K. (1997). Proceedings of the IV International Mesothelioma Conference. University of Pennsylvania, Philadelphia PA, May 13-15. S3, pp. 30.
45. Mark EJ, & Yokoi T. (1991). In: The third wave of asbestos disease: exposure of asbestos in place. Landrigan PJ, and Kazemi H. (eds.), Ann. N.Y. Acad. Sci., 643, 196-204.
46. Maroulakaou IG, Anver M, Garrett L and Green JE. (1994). Proc. Natl. Acad. Sci. USA, 91, 11236-11240.
47. Marsella JM, Liu BL, Vaslet CA, and Kane AB. Environmental Health Perspectives. In press.
48. Marshall J, Smith AE and Cheng SH. (1991). Oncogene, 6, 1673-1676.
49. Martini F, Iaccheri L, Lazzarin L, Carinici P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, and Tognon M. (1996). Cancer Res., 56, 4820-4825.
50. Melnick JL, & Stinbaugh S. (1962). Proc. Soc. Exptl. Biol. Med., 109, 965-968.
51. Melnick JL. (1996). In: Virology. Fields BN, Knipe DM, Howley PM (eds), Lippincott-Raven Publishers, Philadelphia, New York, vol. 1, pp. 655-712.
52. Monini P, de Lellis L and Barbanti-Brodano G. (1995). In: DNA tumor viruses oncogenic mechanisms, Barbanti-Brodano G, Bendinelli M, and Frieman H (eds.), Plenum Publishing Co. New York, NY pp. 51-73.
53. Moorwood K, Price TNC and Mayne LV. (1996). Exp. Cell Res. 223, 308-313.
54. Morris JA, Johnson KM, Aulisio GC, Chanock RM and Knight V. (1961). Proc. Soc. Exptl. Biol. Med., 108, 56-64.
55. Mortimer EA, Lepow ML, Gold E, Robins FC, Burton GJ and Fraumeni JF. (1981). N. Engl. J. Med., 305, 1517-1518.
56. Olin P. (1997). SV40: A possible human polyomavirus workshop. National Institutes of Health, Bethesda, MD. 27-28 Jan. 1997. Transcripts. SAG, Corp. Washington DC 20008. (vol. 1) pp. 315-323.
57. Ozer HL, Banga SS, Dasgupta T, Houghton JM, Hubbard K, Jha KK, Kim SH, Lenhan M, Pang Z, Pardinas JR and Patsalis PC. (1996). Exp. Gerontol. 31, 303-310.
58. Pass HI, Kennedy RC and Carbone M. (1996). In: Important advances in Oncology, Rosenberg SA, Hellman S, and De Vita T (eds.), Lippincott-Raven Publishers, Phildelphia PA, pp. 89-108.
59. Pass HI. (1997). SV40: A possible human polyomavirus workshop. National Institutes of Health, Bethesda, MD. 27-28 Jan. 1997. Transcripts. SAG, Corp. Washington DC 20008. (vol. 1) pp. 180-185.
60. Pepper C, Jasani B, Navabi H, Wynford-Thomas D and Gibbs AR. (1996). Thorax, 51, 1074-1076.
61. Peto J, Hodgson JT, Matthews FE and Jones JR. (1995). The Lancet, 345, 535-539.
62. Price B. (1997). Am. J. Epidemiol, 145, 211-218.
63. Rabson AS, O'Connor GT, Kirschstein RL and Branigan WJ. (1962). J. Natl. Cancer Inst, 29, 766-787.
64. Ray AF. (1995). In: DNA tumor viruses oncogenic mechanisms, Barbanti-Brodano G, Bendinelli M and Frieman H (eds.), Plenum Publishing Co. New York, NY pp. 15-26.
65. Ray AR, Grossman SA, Ronnett BM, Bigner SH, Vogelstein B amd Shah K. (1994). J. Neuro-Oncology, 20, 55-58.
66. Reddel RR, Malan-Shibley L, Gerwin BI, Metcalf RA, and Harris CC. (1989). J. Natl. Cancer Inst., 81, 945-948.
67. Rhim JS, Fujita J, Arnstein P and Aaronson SA. (1986). Science, 232, 385-388.
68. Roggli VL, Sanfilippo F and Sheolburne J. (1992). In: Pathology of asbestos and associated diseases. Roggli VL, Geenberg SD, and Pratt PC. (eds.), Little Brown, Boston pp. 383-391.
69. Ruley EH. (1996). In: Important advances in Oncology, Rosenberg SA, Hellman S and De Vita T. (eds.), Lippincott-Raven Publishers, Phildelphia PA, pp. 89-108.
70. Shah KV and Nathanson N. (1976). Am. J. Epidentiol., 93, 291-297.
71. Shein H and Enders JF. (1962). Proc. Natl. Acad. Sci. USA, 48, 1164-1172.
72. Simmons DT. (1995). In: DNA tumor viruses oncogenic mechanisms, Barbanti-Brodano G, Bendinelli M, and Frieman H (eds.), Plenum Publishing Co. New York, NY. pp. 27-50.
73. Soriano F, Shelburne CE and Gokcen M. (1974). Nature, 249, 421-424.
74. Stoian M, Suru M, losipengo M, Athanasiu P, Nastac E, Arseni C and Alexianu D. (1984). Rev. Roum. Med. Virol., 35, 127-132.
75. Strickler HD. (1997). SV40: A possible human polyomavirus workshop. National Institutes of Health, Bethesda, MD. 27-28 Jan. 1997. Transcripts. SAG, Corp. Washington DC 20008. (vol. 1) pp. 323-340.
76. Strickler HD, Goedert JJ, Fleming M, Travis WD, Williams AE, Rabkin CS, Daniel RW and Shah KV. (1996). Cancer Epidemiology, Biostatistics and Prevention. 5, 473-475.
77. Sweet BH and Hilleman MR. (1960). Proc. Soc. Exptl. Biol. Med., 105, 420-427.
78. Tevethia SS. (1990). Mol. Biol. Med., 7, 83-96.
79. Tieman F, Zerrhan J and Deppert W. (1995). J. Virol., 69, 6115-6121.
80. von der Weth A and Deppert W. (1992). Virology, 189, 334-339.
81. Walsh JW, Zimmer SG and Perdue ML. (1982). Neurosurgery, 10, 643-662.
82. Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinestein LJ, Preziosi TJ and Conley FK. (1972). N. Engl. J. Med., 305, 1517-1518.
83. Weiss AF, Portmann R, Fisher H, Simon J and Zang KD. (1975). Proc. Natl. Acad. Sci. USA, 72, 609-613.